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Abstract Classical swine fever virus (CSFV) Erns is an
envelope glycoprotein possessing RNase activity. The Erns-
based enzyme-linked immunosorbent assay (ELISA) has
been considered a discriminating diagnostic test for differ-
entiating infected from vaccinated animals. The purpose of
this study was to produce a specific monoclonal antibody
(MAb) to Erns for further developing an indirect sandwich
ELISA. The MAb CW813 was shown to specifically
recognize both the monomer and dimer forms of Pichia
pastoris yeast-expressed Erns (yErns). The antigenic site
recognized by MAb CW813 was mapped to the region of
amino acid residues 101–160 of Erns where it was neither a
neutralizing epitope nor essential to RNase activity. Further-
more, MAb CW813 was utilized as a capture antibody to
develop a yErns-based indirect sandwich ELISA for detecting
swine antibody to Erns. The assay demonstrated a high
sensitivity and specificity that may provide an alternative
method for developing a diagnostic kit with easy manipu-
lation and low cost.
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Introduction
Classical swine fever virus (CSFV) belongs to the genus
Pestivirus of the Flaviviridae family (van Rijn et al. 1996).
CSFV infection in swine results in a highly contagious and
severe disease characterized by fever and hemorrhages with
an acute or chronic course (Lindenbach and Rice 2001).
Outbreaks of classical swine fever (CSF) often cause large
economic losses in the pig industry worldwide. The positive-
stranded RNA genome comprises a single, long open reading
frame coding for a polyprotein encompassing all viral
proteins. Structural proteins include a nucleocapsid protein
C and three envelope glycoproteins, Erns, E1, and E2. Both
Erns and E2 are known to induce virus-neutralizing anti-
bodies and mount protective immunity in the natural host
(Bouma et al. 2000; Lin et al. 2009; König et al. 1995; van
Rijn et al. 1996; Weiland et al. 1992). Vaccination with the
live-attenuated CSFV vaccine protects pigs from CSF
(Terpstra and Wensvoort 1988). However, these vaccinated
animals cannot be serologically distinguished from animals
infected with field strains of CSFV, hampering controlled
eradication of CSFV (van Rijn et al. 1996). The E2 subunit
vaccine recently developed against CSFV has been consid-
ered a potential marker vaccine for serological discrimination
between vaccinated and infected pigs that can be performed
by detecting of antibodies against Erns (Bouma et al. 2000;
de Smit 2000; Moormann et al. 2000).
The Erns glycoprotein forms as a disulfide-bonded
homodimer with an apparent size of 97 kDa, and about
half the molecular mass of the mature Erns glycoprotein is
made up of carbohydrates (Meyers and Thiel 1995;
Rumenapf et al. 1993). Erns has been identified as an
RNase, and two sequence stretches of Erns show sequence
homology to members of the Rh/T2/S RNase superfamily
(Schneider et al. 1993; Hulst et al. 1994; Langedijk et al.
C.-W. Wu : T.-Y. Liu :G.-J. Lin : C. Huang (*)
Graduate Institute of Microbiology and Public Health College
of Veterinary Medicine, National Chung Hsing University,
250 Kuo Kuang Road,
Taichung 40227, Taiwan, Republic of China
e-mail: cjhuang@dragon.nchu.edu.tw
M.-S. Chien :W.-C. Lee
Graduate Institute of Veterinary Pathobiology, College
of Veterinary Medicine, National Chung Hsing University,
250 Kuo Kuang Road,
Taichung 40227, Taiwan, Republic of China
Appl Microbiol Biotechnol (2011) 92:815–821
DOI 10.1007/s00253-011-3602-y
2002). Erns lacks a typical transmembrane anchor and is
secreted from infected cells. The biological function of Erns
RNase activity is not fully understood; however, destruc-
tion of the RNase activity by mutations gives rise to viruses
that are more cytopathic in culture and attenuated in vivo
(Hulst et al. 1998; Meyers et al. 1999).
Expression of Erns in eukaryotic cells infected by
recombinant baculovirus (Hulst et al. 1994) or vaccinia virus
(König et al. 1995) has been reported. Recently, an active
Erns has been produced using the yeast Pichia pastoris
secreted expression system, and this yeast-expressed Erns
(yErns) demonstrated intrinsic ribonuclease activity with a
clear preference for the uridine-rich sequence (Huang et al.
2006). The yErns also showed correct conformation that
could be applied to substitute the Erns antigen in a
commercial sandwich blocking enzyme-linked immunosor-
bent assay (ELISA) kit for detecting specific antibodies
against Erns. In the present study, a monoclonal antibody
(MAb) which specifically recognized yErns was established
and characterized. This MAb was further utilized as a
capture antibody to develop an indirect sandwich ELISA of
which the diagnostic specificity and sensitivity for detecting
antibody to Erns were evaluated.
Materials and methods
Construction of recombinant plasmid
Plasmid pE23 ml containing the CSFV glycoprotein gene
fragment (Erns-E1-E2) of Taiwan isolate p97 was constructed
previously (Shiu et al. 1996). The full length of the Erns
coding region was amplified by polymerase chain reaction
(PCR) using pE23 ml as a template with a specific primer
pair corresponding to the Erns sequence (the forward primer
F1: 5′-GTGGATCCGAAAATATAACTC-3′; the reverse
primer R227: 5′-GTACTCGAGGGCATAGGCACCGA-3′)
according to the GenBank accession nos. U43924 and
U03290. The primer sequences recognized by the restriction
enzyme BamHI or XhoI are underlined, and the PCR
reaction was carried out as described previously (Huang et
al. 2006). The fragment of the Erns gene was gel-purified and
digested with restriction enzymes BamHI/XhoI followed by
cloning into the expression vector pET32a (Novagen) to
generate the recombinant plasmid pET32/E0N227. Various
DNA fragments encoding a series of C-terminal deletions
were prepared by PCR using a primer pair of F1 and
appropriate reverse primer (R190: 5′-GTACTCGAG
TATGGTATTAGTCATT-3′, R160: 5′-GTACTCGAGG
GAAACGTTAAAATTA-3 ′ , R100: 5 ′ -GTACTC
GAGGTTCGCTTGGGTTCT-3′, and R50: 5′-GTACTC
GAGTTCCGTGTCTGTAGCC-3′) followed by cloning into
pET32a to generate pET32/E0N190, pET32/E0N160,
pET32/E0N100, and pET32/E0N50, respectively. All the
recombinant plasmids were sequenced to confirm the
accuracy of the open reading frame of Erns coding sequences.
Expression of Erns in Escherichia coli and yeast
The recombinant plasmid was transformed into E. coli BL21
(DE3) competent cells according to the manufacturer’s
manual. A single colony of transformants was grown in
Luria-Bertani medium containing 50 μg/ml ampicillin at
37 °C until the OD600 reached 0.6. Then, isopropyl
β-D-thiogalactopyranoside (IPTG) was added to a final
concentration of 1 mM. The culture was incubated for an
additional 3 h at 37 °C. The cells were harvested by
centrifugation and resuspended in 100 mM Tris–HCl (pH
8.0) containing 1 mM EDTA. Cells were broken by
sonication; insoluble material was collected by centrifugation
at 15,000×g for 10 min at 4 °C, and solubilized proteins
were analyzed by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE). The expressed protein
was further identified by recognition of anti-His antibody
(Amersham) in Western blotting assay. The expressed protein
was further purified by metal affinity chromatography using
nickel–nitrilotriacetic acid (Ni–NTA) resin (QIAGEN)
according to the manufacturer’s manual.
A single colony of recombinant Erns-expressing P. pastoris
(Huang et al. 2006) was inoculated in 5 ml yeast extract
peptone dextrose (YPD; 1% yeast extract, 2% peptone, 2%
glucose) medium and incubated at 30 °C in a shaking
incubator (250 rpm) overnight. Then, 0.1 ml of the overnight
culture was transferred to 50 ml fresh YPD medium in a 250-
ml baffled flask and was continuously incubated for 4 days.
The supernatants were clarified by centrifugation (20 min,
12,000×g, 4 °C), and secreted protein was concentrated by
Vivaspin 20 concentration column (Sartorius), followed by
dialysis against phosphate-buffered saline (PBS).
Western blotting analysis
Expressed proteins were resuspended in equal volumes of
2× SDS-PAGE sample buffer (125 mM Tris–Cl [pH 6.8],
20% glycerol, 4% SDS, 10% β-mercaptoethanol, 0.25%
bromophenol blue). Proteins were separated by 12% SDS-
PAGE and transferred by electroblotting onto PolyScreen
PVDF transfer membrane (NEN) using semi-dry transfer
cell (Bio-Rad) according to the manufacturer’s manual. The
membrane was then treated sequentially with blocking
solution (PBS containing 5% non-fat skim milk), with
appropriate dilution of anti-His antibody (Serotec) and with
anti-mouse IgG goat antibody conjugated to peroxidase
(Zymed). Finally, the membrane was soaked in a chromo-
gen/substrate solution (TMB single solution; Zymed) for
color development, or the signal was detected by chemilu-
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minescence substrate (ECL reagent, Amersham Pharmacia
Biotech) and visualized by autoradiography.
Preparation of the monoclonal antibody against Erns
Five 6-week-old female BALB/c mice were immunized
subcutaneously with 0.5 ml of a mixture of 40 μg purified
E. coli-expressed Erns (N227) and an equal volume of
Freund’s complete adjuvant (Sigma). A similar immuniza-
tion was given 2 weeks later using Freund’s incomplete
adjuvant. After an additional 3 weeks, the immunized mice
received intraperitoneally a final booster with 0.5 ml of 40 μg
purified Erns without adjuvant. The fusion was carried out
5 days later according to the methods described previously
(Huang et al. 1994). The hybridoma secreting specific
antibody to Erns was selected by ELISA and further
characterized by Western blotting analysis. The subclass of
theMAbwas determined byMouseMonoAb-ID kit (Zymed).
Neutralization assay
The neutralizing antibody activity to CSFV was determined
as described previously (Terpstra et al. 1984). Replicates of
twofold dilutions of MAb (50 μl) were mixed with 200
TCID50 CSFV p97 strain (50 μl) in microtitration plate and
incubated at 37 °C for 1 h. After adding 1×104 PK-15 cells
(100 μl) and incubation at 37 °C for 72 h, the cells were
subjected to immunofluorescence staining with the MAb
WH303 specific to CSFV E2 (Veterinary Laboratory
Agency). Neutralizing titers were expressed as the reciprocal
of the highest dilution that caused complete neutralization.
RNase activity assay
The RNase activity of expressed Erns degrade polymeric
substrate specificity was measured by perchloric acid
precipitation as described previously (Windisch et al. 1996)
with some modifications. The recombinant Erns protein was
incubated with 80 μg of polyU RNA homopolymer in
100 μl renaturing buffer at 37 °C for 60 min. The reaction
was stopped by the adding 100 μl of 1.2 M perchloric acid–
25 mM lanthanum sulfate. After 1 h incubation on ice and
15 min of centrifugation (15,000×g, 4 °C), the A260 of the
supernatant was measured by spectrophotometer (Hitachi
U-2800A). Each reaction was tested in triplicate, and the
optical density (OD) of triplicates was averaged.
Serum samples
Fifty-four swine serum samples were collected from the
Animal Disease Diagnostic Center, College of Veterinary
Medicine, National Chung Hsing University, including eight
SPF, nine baculovirus-expressed E2 vaccine-immunized
(BacE2), 19 LPC attenuated vaccine-immunized (LPC), and
eight negative (Erns−), as well as ten positive (Erns+) field
sera were determined by the commercial Erns blocking
ELISA kit (IDEXX). All the SPF and BacE2 sera were
classified as negative and those of LPC as positive by the
IDEXX ELISA kit.
Indirect sandwich ELISA
ELISA plates (Corning) were coated at 4 °C overnight
with 50 μl of 1:2 diluted culture supernatant of MAb
against Erns in coating buffer (carbonate buffer, pH 9.6).
The capture plate was then thoroughly washed with PBS
containing 0.05% Tween-20 (PBST) and blocked with
blocking buffer (PBS containing 1% bovine serum
albumin) at 37 °C for 1 h. After washing, each well
received 50 μl of appropriate dilution of yErns antigen in
blocking buffer and was incubated at 37 °C for 1 h. After
washing, each well received 50 μl of appropriately diluted
Fig. 1 Expression of Erns and deletion mutants in E. coli. a Schematic
diagrams of CSFV Erns deletion mutants. Bars represent expressed
Erns sequences and the amino acid residue numbers at both termini are
indicated. b–c Characterization of expressed Erns and deletion
mutants. Plasmid pET32a (lane 6) or recombinant plasmids including
pET32/E0N227- (lane 1), pET32/E0N190- (lane 2), pET32/E0N160-
(lane 3), pET32/E0N100- (lane 4), and pET32/E0N50- (lane 5)
transformed E. coli cells were subjected to induction expression with
1 mM IPTG for 3 h. The cellular lysates were harvested and then
purified with Ni–NTA affinity chromatography for SDS-PAGE (14%)
analysis (b) and Western blotting analysis using anti-His antibody (c).
The location of each expressed protein is indicated by an arrow
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tested swine serum in blocking buffer and was incubated
at 37 °C for 1 h. Subsequently, the plate was washed with
PBST thoroughly, and each well received 50 μl of 2,000-
fold dilution of goat anti-swine IgG conjugated to
peroxidase (Zymed) in blocking buffer at 37 °C for
45 min. Finally, the plate was washed with PBST three
times and PBS twice. Then, 50 μl of freshly prepared
chromogen/substrate solution (ABTS single solution,
Zymed) was added into each well, and the plate was
incubated at room temperature for 15 min. The optical
density of each well was read at 405 nm using a
microplate reader (MRXII, Dynex). Each sample was
analyzed in duplicate, and the OD of duplicates was
averaged.
Fig. 2 Characterization of the
specificity and epitope mapping
of MAb CW813 by Western
blotting analysis. aYeast-
expressed Erns in the presence of
β-mercaptoethanol (lane 1) and
absent (lane 2) were recognized
by the MAb CW813. The
monomer or homodimer form of
yErns is indicated by an arrow.
The wild-type yeast-secreted
proteins (lane 3) were included
as controls. b The reactivities of
MAb CW813 to the full length
of Erns N227 (lane 1) and
deletion mutants N190, N160,
N100, and N50 (lanes 2–5,
respectively) were analyzed for
epitope mapping
Fig. 3 Analysis of RNase activity of yErns after reacting with MAb
CW813. One microgram of purified yErns was reacted with MAb
CW813 at 37 °C for 1 h and then incubated with 80 μg of poly(U)
RNA homopolymer. The RNA-degrading activity was determined by
measuring the absorbance at 260 nm due to the release of acid-soluble
RNA as described in “Materials and methods”. E. coli-expressed
N227, N190, N160, N100, and N50 were coincidently analyzed to
determine their RNase activity. The pET32 tag protein, assay buffer,
and RNase Awere used as negative and positive controls, respectively.
The bars show the relative RNase activity as a percentage when using
absorbance of RNase A at 100%
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Results
Expression of Erns and subunits in E. Coli
Recombinant plasmid pET32/E0N227 containing the full
length of the coding region of CSFV Erns was constructed to
express the Erns protein (N227) for preparation of MAb
against Erns. A series of C-terminal deletion mutants
encoding the N-terminal 190 (N190), 160 (N160), 100
(N100), and 50 (N50) residues, respectively, were also
constructed for further mapping the epitope recognized by
the MAb (Fig. 1a). The expressed proteins which fused to a
C-terminal His-tag were analyzed by SDS-PAGE (Fig. 1b)
and confirmed by Western blotting analysis with anti-His
antibody (Fig. 1c).
Characterization of the MAb against the CSFV Erns
A stable hybridoma which secreted antibody reacting
specifically with Erns N227 was selected and cloned. The
MAb was determined to be the type of IgG1 subclass (data
not shown) and denominated CW813. The MAb CW813
could specifically recognize both the monomer and dimer
forms of yErns by the Western blotting analysis (Fig. 2a). In
addition, the MAb CW813 could recognize N190 and N160
but not N100 and N50 (Fig. 2b), thus the epitope
recognized by the MAb CW813 was mapped to the region
of the amino acid residues 101–160. Furthermore, the MAb
CW813 neither demonstrated neutralizing antibody activity
in the neutralization assay (data not shown) nor blocked the
RNase activity of yErns (Fig. 3).
Development of the indirect sandwich ELISA
Since Erns is highly glycosylated resulting in inefficient
binding to the plate, twofold dilution of MAb CW813
culture supernatant was coated on ELISA plate to capture
the antigen yErns. The optimal concentration of the yErns
was determined by checkerboard titration. The best positive/
negative ratio was obtained when the yErns was diluted at a
concentration of 35 μg/ml, and the tested swine serum was
diluted at 1:50. Fifty-four swine serum samples were tested
by indirect sandwich ELISA, and the results expressed as
OD values at 405 nm (OD405) are shown in Fig. 4. Mean
OD405 of eight SPF sera was 0.1936, and the standard
deviation (SD) was 0.0287. When the positive/negative cut-
off value was set at mean plus 2 standard deviations (mean+
2 SD=0.2611), among 25 negative sera including those from
SPF, BacE2, and Erns-, 18 were determined as negative and
resulted in a specificity of 72% (18/25×100%). However, all
the positive sera including those from LPC and Erns+ were
positive with the corresponding sensitivities of 100% (29/
29×100%). The specificity increased to 100% when the cut-
off value was set at mean plus 3 standard deviations (mean+
3SD=0.2799) with the corresponding sensitivities of 96.6%
(28/29×100%). A summary of the cut-off values and
sensitivities of the indirect sandwich ELISA to yErns are
shown in Table 1.
Discussion
CSF is an economically important swine disease that has
received widespread attention. Detecting antibodies to Erns
and E2 in swine serum provides a direct measure of the
immune status of animals that had been vaccinated or
Fig. 4 Reactivities of swine sera from different sources to yErns in the
indirect sandwich ELISA. Twenty-five negative (Erns-, BacE2, and
SPF) and 29 positive (Erns+ and LPC) serum samples were tested for
reactivity with yErns as described in “Materials and methods”
Table 1 Summary of cut-off value, specificity, and sensitivity of the
indirect sandwich ELISA to yErns
Cut-off value OD value Specificity (%) Sensitivity (%)
Mean+ 2 SD 0.2611 72 (18/25) 100 (29/29)
Mean+ 3 SD 0.2799 100 (25/25) 96.6 (28/29)
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CSFV infected (König et al. 1995; Weiland et al. 1992).
Currently, commercially available diagnostic ELISA kits
mostly use baculovirus-expressed recombinant E2 or Erns as
ELISA antigens (Windisch et al. 1996; Moormann et al.
2000). However, the cost of insect cell culture and time-
consumption to purify the expressed product are major
concerns. A more economical yErns recombinant protein
has been demonstrated to be a useful antigen in a sandwich
blocking ELISA (Huang et al. 2006). In the present study, a
yErns-based indirect sandwich ELISA was established that
could offer an inexpensive assay for detecting antibody to
Erns with simplicity and easy interpretation. Since yErns has
similar highly glycosylated conformation to native Erns, the
binding of yErns to the ELISA plate was greatly improved
by the capture with MAb CW813. Although lectins have
been used widely in the capture or detection of glycoproteins
(Yue et al. 2009), binding of a specific antigen by the
monoclonal antibody is more efficient that nonspecific
reactions could be reduced. This MAb was originally
screened against E. coli-expressed Erns (N227) and further
selected for high specificity to yErns by Western blotting
analysis (Fig. 2a). The epitope recognized by CW813 was
mapped to the middle region of Erns at amino acid residues
101–160. This was not a neutralizing antigenic site due to
the absence of neutralizing activity of CW813.
The CSFV Erns contains RNase activity, which is unique
for viral surface proteins (Schneider et al. 1993; Windisch
et al. 1996; Langedijk et al. 2002). The role played by Erns
in viral pathogenesis is not well characterized. Binding with
MAb CW813 did not block the RNase activity of yErns,
suggesting the residues within the epitope recognized by
CW813 were not essential to RNase activity. However, E.
coli-expressed Erns (N227) and two truncation mutants,
N190 and N160, also revealed RNase activity (Fig. 3). This
result indicates the N-terminal 160 residues of Erns are
sufficient for RNase activity, and the region of residues 101–
160 besides the unessential epitope of CW813 may contain
indispensable sequences contributing to the RNase activity.
In addition, glycosylation of Erns is seemingly dispensable
for the RNase activity since both E. coli-expressed Erns and
deglycosylated yErns (Huang et al. 2006) possess enzymatic
activity. The structure and function of Erns and the
mechanism of RNase catalysis remain elusive.
Furthermore, the results of yErns-based indirect sandwich
ELISA clearly demonstrate discriminative reactivities be-
tween conventional whole live vaccine (LPC) and E2 subunit
(BacE2) vaccinated pigs (Fig. 4). Thus, this ELISA may
offer a useful diagnostic test to distinguish infected and
vaccinated animals. In conclusion, a monoclonal antibody
specific to the CSFV Erns was established and applied to
develop an indirect sandwich ELISA for detecting the
antibody to Erns. This yeast-expressed Erns-based indirect
sandwich ELISA demonstrated a high sensitivity and
specificity that may provide an alternative method for
developing a discriminating diagnostic kit with easy manip-
ulation and low cost.
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